查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970950

無乳糖嬰兒配方奶粉市場－全球產業規模、佔有率、趨勢、機會和預測（按產品類型、銷售管道、地區和競爭格局分類，2021-2031年）

Lactose-free Infant Formula Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Product Type, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球無乳糖嬰兒奶粉市場預計將從 2025 年的 212.2 億美元成長到 2031 年的 317.2 億美元，複合年成長率為 6.93%。

這些專門配製的母乳替代品旨在為患有次發性、原發性或先天性乳糖不耐受的嬰兒提供營養，不含乳糖，而是使用蔗糖、麥芽糊精和玉米糖漿固態等替代碳水化合物。市場成長的主要促進因素包括臨床診斷的新生兒胃腸道高反應性盛行率的上升，以及職業父母對可靠且易於消化的餵食方式日益成長的需求。因此，當無法進行母乳哺育時，穩定供應安全、科學研發的替代品至關重要。

市場概覽
預測期 2027-2031
市場規模：2025年 212.2億美元
市場規模：2031年 317.2億美元
複合年成長率：2026-2031年 6.93%
成長最快的細分市場 線上
最大的市場 歐洲

另一方面，由於嚴格的法律規範和全球公共衛生舉措提倡純母乳餵養，該行業面臨巨大的阻力，這可能會限制配方奶粉的廣泛應用。儘管存在這些監管障礙，該行業仍保持著巨大的經濟影響力。根據歐洲特殊營養協會（Specialised Nutrition Europe）2024年的報告顯示，包括嬰兒奶粉奶粉在內的特殊營養品產業年銷售額接近240億歐元。這項數據凸顯了針對弱勢群體量身定做的特殊營養解決方案的巨大商業性價值。

市場促進因素

次發性和先天性乳糖不耐症以及牛奶蛋白過敏的臨床診斷日益增多，推動了市場成長，因為醫療需求促使人們使用特殊的營養配方奶粉。無法消化乳糖或對牛蛋白有嚴重反應的新生兒需要即時用氨基酸或水解蛋白配方奶粉替代正餐，以預防胃腸道併發症，從而產生了對治療性嬰兒奶粉的穩定且非週期性需求。此細分市場的規模體現在主要生產商的業績。根據雅培公司於2024年10月發布的“2024年第三季財務業績”，其兒童營養業務（包括消化器官系統過敏配方奶粉）在上半年實現了30.23億美元的全球銷售額。

同時，家長們日益關注動物福利和成分透明度，推動了有機和植物來源幼兒配方奶粉需求的成長，這成為重要的次要促進因素。越來越多的家長傾向於選擇天然不含乳糖的杏仁、蕎麥和大豆配方奶粉，這些產品兼顧了倫理價值和消化功能需求。這一趨勢使得一些小眾品牌能夠透過潔淨標示創新來鞏固自身市場地位。例如，Els Nutrition Holdings在2024年4月發布的「2023會計年度報告」中公佈，其年銷售額達到940萬加元，展現了非乳製品嬰幼兒營養品的商業性潛力。業界領導企業利潔時集團(Reckitt Benckiser Group PLC)的舉措也進一步印證了該領域的強勁勢頭。該公司在2024年2月發布的「2023會計年度財務業績報告」中指出，其營養品部門的淨銷售額達到24.1億英鎊，凸顯了其在全球範圍內對嬰幼兒營養管理領域的重大投資。

市場挑戰

全球無乳糖嬰兒奶粉市場面臨的主要障礙是嚴格的法規環境和日益增強的倡導純母乳哺育的公共衛生運動。這些由各國政府根據國際衛生目標實施的宣傳活動，正日益限制奶粉的供應、標籤和行銷，將其明確定位為次要選擇而非主要選擇。這種監管環境不僅限制了品牌曝光度，而且從根本上縮小了潛在基本客群，因為它強烈鼓勵父母在嬰兒早期關鍵階段推遲或放棄使用其他替代品。

這些宣傳活動的具體市場影響在關鍵地區持續高企的純母乳哺育率中顯而易見，直接限制了配方奶粉的潛在市場。例如，根據英國專業營養協會 (BSNA) 2024 年的報告，英格蘭約有 29.3% 的嬰兒在 6-8 週大時接受純母乳哺育。這項數據表明，公共衛生訊息在影響父母的餵食選擇方面卓有成效，並為新生兒期乳糖不耐受配方奶粉的廣泛應用設置了永久性障礙。

市場趨勢

添加人類乳寡糖 (HMO) 是該行業一項重要的技術轉折點，它從單純去除乳糖發展到積極模擬母乳複雜的免疫特性。雖然傳統的無乳糖嬰兒奶粉能有效預防消化器官系統問題，但它們歷來缺乏在脆弱的嬰兒體內培養健康腸道菌叢所需的益生元成分。因此，製造商開始在配方中添加生物同源性 HMO，例如 2'-岩藻糖基乳糖，以在不添加乳糖的情況下支持腸道屏障功能和有益菌叢。這些高價值成分的商業性成功從主要供應商的業績中可見一斑。在 2025 年 2 月發布的「2024 年全年業績報告」中，dsm-firmenich 公佈了 127.99 億歐元的總銷售額，成長主要得益於其健康、營養與護理部門的創新主導成長，該部門正是這些先進成分的供應商。

同時，向環保永續包裝的轉變正在改變市場的營運結構。這主要得益於家長環保意識的增強以及監管要求淘汰新材料的推動。製造商正在逐步淘汰用於一次性營養品的傳統塑膠湯匙和複合罐，轉而使用生物基塑膠、完全可回收的錫和紙質包裝，以減少與一次性營養品相關的碳排放。這種向循環經濟原則的策略性轉變，不僅意味著遵循成本，更成為一種競爭優勢。正如達能在2025年3月發布的《2024會計年度財務報告》中所指出的，集團透過有效實施「Renew」策略，實現了4.3%的同店銷售成長。該策略強調在其所有特種營養產品系列中實現環境管理和永續價值創造。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球無乳糖奶粉市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按產品類型（有機、傳統）
    • 銷售管道（超級市場/大賣場、便利商店、線上、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美無乳糖配料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲無乳糖奶粉市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區無乳糖嬰兒爽身粉市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲無乳糖奶粉市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美無乳糖配料奶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球無乳糖奶粉市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Nestle SA
  • Ausnutria Dairy Corporation Ltd.
  • Valio Ltd
  • Abbott Laboratories
  • Bubs Australia Limited
  • Danone SA
  • Reckitt Benckiser Group PLC
  • Perrigo Company plc
  • Dana Dairy Group LTD
  • Hero AG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 26725

The Global Lactose-free Infant Formula Market is projected to expand from USD 21.22 Billion in 2025 to USD 31.72 Billion by 2031, registering a CAGR of 6.93%. These specialized breast milk substitutes are engineered without lactose, utilizing alternative carbohydrates like sucrose, maltodextrin, or corn syrup solids to nourish infants suffering from secondary, primary, or congenital lactose intolerance. Market growth is fundamentally underpinned by key factors such as the growing prevalence of clinically diagnosed neonatal digestive sensitivities and the escalating need among working parents for reliable, digestible feeding options, necessitating the consistent availability of safe, scientifically developed alternatives when breastfeeding is not feasible.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 21.22 Billion
Market Size 2031USD 31.72 Billion
CAGR 2026-20316.93%
Fastest Growing SegmentOnline
Largest MarketEurope

Conversely, the sector encounters substantial headwinds arising from rigorous regulatory structures and global public health initiatives that champion exclusive breastfeeding, potentially limiting the broader uptake of formula products. Despite these regulatory barriers, the industry maintains a massive economic presence. As reported by Specialised Nutrition Europe in 2024, the specialized nutrition sector, which includes the infant formula category, achieved an annual turnover nearing 24 billion EUR. This statistic highlights the significant commercial impact of specialized dietary solutions tailored for vulnerable populations.

Market Driver

The escalating clinical identification of secondary and congenital lactose intolerance, coupled with cow's milk protein allergies, acts as a major engine for market growth, as medical requirements necessitate the use of specialized nutritional formulas. Newborns unable to digest lactose or those suffering severe reactions to bovine proteins demand immediate dietary replacement with amino acid or hydrolyzed protein-based formulas to avert gastrointestinal complications, creating a steady, non-cyclical demand for therapeutic infant nutrition. The financial scale of this segment is reflected in the results of major manufacturers; according to Abbott's 'Third-Quarter 2024 Results' released in October 2024, their Pediatric Nutrition division, comprising formulations for digestive sensitivities, achieved global sales of 3,023 million USD in the fiscal year's first nine months.

Concurrently, the increasing appetite for organic and plant-based formula options serves as a crucial secondary driver, fueled by parental concerns regarding animal welfare and ingredient transparency. Caregivers are increasingly favoring almond, buckwheat, or soy-based formulations that naturally lack lactose, harmonizing ethical values with functional digestive needs, a trend that has allowed niche players to gain ground through clean-label innovations. For instance, Else Nutrition Holdings Inc. reported in its 'Year End 2023 Financial Results' in April 2024 that it secured annual revenue of 9.4 million CAD, demonstrating the commercial potential of non-dairy infant nutrition. The sector's broader strength is further evidenced by industry leaders like Reckitt Benckiser Group PLC, which reported in February 2024 within its 'Full Year 2023 Results' that its Nutrition unit generated net revenue of 2,410 million GBP, highlighting significant global investment in specialized infant dietary management.

Market Challenge

A significant obstacle facing the Global Lactose-free Infant Formula Market involves strict regulatory environments and intensified public health movements that promote exclusive breastfeeding. These campaigns, aligned with international health objectives and implemented by national authorities, increasingly curtail the availability, labeling, and marketing of formula, categorizing it firmly as a secondary recourse rather than a primary option. Such a regulatory landscape not only restricts brand exposure but also fundamentally narrows the potential customer base during the crucial early stages of infancy, as parents are heavily urged to postpone or forgo the use of substitutes.

The tangible market effect of these advocacy initiatives is evident in the continued high rates of exclusive breastfeeding in major regions, which directly limits the addressable market for formula products. For example, the British Specialist Nutrition Association reported in 2024 that roughly 29.3% of infants in England were being exclusively breastfed at six to eight weeks of age. This statistic underscores the efficacy of public health messaging in shaping parental feeding choices, thereby establishing an enduring impediment to the widespread acceptance of lactose-free formula solutions during the newborn phase.

Market Trends

The incorporation of Human Milk Oligosaccharides (HMOs) marks a pivotal technological shift in the industry, evolving from mere lactose elimination to actively mimicking breast milk's complex immunological attributes. While traditional lactose-free formulas effectively prevent digestive issues, they have historically lacked the prebiotic elements needed to cultivate a healthy gut microbiome in vulnerable infants, prompting manufacturers to enrich recipes with bio-identical HMOs like 2'-Fucosyllactose to support barrier function and beneficial bacteria without adding lactose. The commercial success of integrating these high-value ingredients is clear from major supplier performance; dsm-firmenich reported in its 'Full Year 2024 Results' in February 2025 that it achieved total sales of 12,799 million EUR, largely fueled by innovation-driven growth in its Health, Nutrition & Care unit, which provides these advanced components.

In parallel, the shift toward Eco-Friendly and Sustainable Packaging is transforming the market's operational structure, driven by parental environmental awareness and regulatory mandates to abandon virgin materials. Manufacturers are progressively swapping traditional plastic scoops and composite tins for bio-based plastics, fully recyclable tinplate, and paper-based outer shells to lower the carbon emissions linked to single-use nutrition products. This strategic move towards circular economy principles is emerging as a competitive advantage rather than a mere compliance expense; as noted in Danone's 'Universal Registration Document - Annual Financial Report 2024' from March 2025, the group realized like-for-like sales growth of 4.3%, attributed to the effective implementation of its 'Renew' strategy which emphasizes environmental stewardship and sustainable value creation across its specialized nutrition range.

Key Market Players

  • Nestle S.A.
  • Ausnutria Dairy Corporation Ltd.
  • Valio Ltd
  • Abbott Laboratories
  • Bubs Australia Limited
  • Danone S.A.
  • Reckitt Benckiser Group PLC
  • Perrigo Company plc
  • Dana Dairy Group LTD
  • Hero AG

Report Scope

In this report, the Global Lactose-free Infant Formula Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactose-free Infant Formula Market, By Product Type

  • Organic
  • Conventional

Lactose-free Infant Formula Market, By Sales Channel

  • Supermarket/Hypermarket
  • Convenience Stores
  • Online
  • Others

Lactose-free Infant Formula Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactose-free Infant Formula Market.

Available Customizations:

Global Lactose-free Infant Formula Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lactose-free Infant Formula Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Organic, Conventional)
    • 5.2.2. By Sales Channel (Supermarket/Hypermarket, Convenience Stores, Online, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Lactose-free Infant Formula Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lactose-free Infant Formula Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Canada Lactose-free Infant Formula Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Mexico Lactose-free Infant Formula Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Sales Channel

7. Europe Lactose-free Infant Formula Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lactose-free Infant Formula Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. France Lactose-free Infant Formula Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Lactose-free Infant Formula Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Lactose-free Infant Formula Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Lactose-free Infant Formula Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Lactose-free Infant Formula Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Lactose-free Infant Formula Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Lactose-free Infant Formula Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. Japan Lactose-free Infant Formula Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. South Korea Lactose-free Infant Formula Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Lactose-free Infant Formula Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Lactose-free Infant Formula Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Lactose-free Infant Formula Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. UAE Lactose-free Infant Formula Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. South Africa Lactose-free Infant Formula Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Sales Channel

10. South America Lactose-free Infant Formula Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Lactose-free Infant Formula Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Colombia Lactose-free Infant Formula Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. Argentina Lactose-free Infant Formula Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Lactose-free Infant Formula Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Nestle S.A.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Ausnutria Dairy Corporation Ltd.
  • 15.3. Valio Ltd
  • 15.4. Abbott Laboratories
  • 15.5. Bubs Australia Limited
  • 15.6. Danone S.A.
  • 15.7. Reckitt Benckiser Group PLC
  • 15.8. Perrigo Company plc
  • 15.9. Dana Dairy Group LTD
  • 15.10. Hero AG

16. Strategic Recommendations

17. About Us & Disclaimer